This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Claude H. Organ, Jr, MD; William R. Fry, MD

JAMA. 1992;268(3):413-414.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The impact of molecular biology during 1991 has attained increased importance in the understanding of processes affecting and caused by surgical procedures. Unresectable tumors and the inability of the body to cope with diseased tissues that continue to perform normal functions still require extirpation. Prevention of complications induced by surgical intervention, such as postoperative infection, is beginning to be understood.

Parekh et al¹ reported in experimental animals that FOY-305, which stimulates the release of endogenous cholecystokinin, caused both hypertrophy and hyperplasia of pancreatic remnants following distal pancreatectomy. If this can be duplicated in humans, it could have significant implications for patients undergoing pancreatectomy or in patients with pancreatic exocrine insufficiency.

Cheadle et al² confirmed that peripheral blood monocytes HLA-DR are a reliable marker for clinically significant surgical infections. Clarification of the deficits associated with this marker may open up new methods of prophylaxis and treatment for surgically related . . . [Full Text PDF of this Article]

Author Affiliations
University of California, Davis—East Bay, Oakland

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?